Tel: (857) 239-0968 / (617) 419-7131
Home > FGFR
Cat.No. Product Name Information Area
T3492 PD-166866 PD166866 is a selective FGFR tyrosine kinase inhibitor with an IC50 of 52.4 nM . Cancer
T3466 FIIN-3 FIIN-3 is an irreversible inhibitor of FGFR1-4 with IC50s of 13, 21, 31, and 35 nM, r... Cancer
T3456 BLU-554 BLU-554 is a potent fibroblast growth factor receptor 4 (FGFR4) inhibitor. Cancer
T3726 Erdafitinib Erdafitinib is a quinoxaline derivative compound, acts on FGFR1/2/3/4 with mean pIC50... Cancer
T3714 SUN 11602 SUN11602 is a novel aniline compound, which mimics the neuroprotective mechanisms of ... Nervous system
T3274 S49076 S49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3. S49076 potently b... Cancer
T6996 SU5402 SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 ... Others
T6836 FIIN-2 FIIN-2 is an irreversible, pan-FGFR inhibitor with IC50 of 3.09 nM, 4.3 nM, 27 nM and... Others
T6124 Mubritinib (TAK 165)new Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM; no activi... Cancer
T6082 SSR128129E SSR128129E is an orally-active and allosteric FGFR1 inhibitor with IC50 of 1.9 μM, wh... Cancer
T6024 CH5183284 (Debio-1347) CH5183284 is a selective and orally available FGFR inhibitor with IC50 of 9.3 nM, 7.6... Cancer
T3074 CHIR98014 CHIR 98014 is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free a... Cancer
T3068 AT9283 AT9283 is a potent JAK2/3 inhibitor with IC50 of 1.2 nM/1.1 nM in cell-free assays; a... Cancer
T2642 PD173074 PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 wit... Cancer
T2638 Gandotinib (LY2784544) LY2784544(gandotinib) is a potent JAK2 inhibitor with IC50 of 3 nM, effective in JAK2... Cancer
T2620 G-749 G-749 is a novel and potent FLT3 inhibitor with IC50 of 0.4 nM, 0.6 nM and 1 nM for F... Cardiovascular System
T2576 Brivanib alaninate Brivanib alaninate (BMS-582664) is the prodrug of BMS-540215, an ATP-competitive inhi... Cancer
T2446 KI8751 Ki8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM, >40-fold se... Cancer
T2372 Ponatinib Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2,... Cardiovascular System
T2361 LY2874455 LY2874455 is a pan-FGFR inhibitor with IC50 of 2.8 nM, 2.6 nM, 6.4 nM, and 6 nM for F... Cancer
T2347 BLU9931 BLU9931 is the first selective small molecule inhibitor of FGFR4 with IC50 of 3 nM; l... Cancer
T2215 Ferulic Acid Ferulic Acid is a hydroxycinnamic acid and a type of organic compound found in the Fe... Immunology
T1975 BGJ398 (NVP-BGJ398) BGJ398 (NVP-BGJ398) is a potent and selective FGFR inhibitor for FGFR1/2/3 with IC50 ... Other
T1948 AZD4547 AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2... Other
T1895 SKLB610 SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kin... Cancer
T1792 Regorafenib Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDG... Cancer
T1777 BIBF 1120 Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1... Other
T1639 Amlexanox Amlexanox (AA673; CHX3673) is a specific inhibitor of IKKε and TBK1; inhibition of IK... Respiratory system
T1537 Rapamycinhot Sirolimus is a mTOR Inhibitor Immunosuppressant. Cancer
T0213 Thalidomide Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo. Immunology